BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2023 8:26:32 AM | Browse: 98 | Download: 222
 |
Received |
|
2023-05-29 14:59 |
|
Peer-Review Started |
|
2023-05-29 15:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-06-19 07:25 |
|
Revised |
|
2023-07-13 12:31 |
|
Second Decision |
|
2023-07-28 02:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-07-28 07:33 |
|
Articles in Press |
|
2023-07-28 07:33 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-08-17 05:52 |
|
Publish the Manuscript Online |
|
2023-08-25 08:26 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anwar Khedr, Hussam Al Hennawi, Muhammed Khuzzaim Khan, Aalaa Eissa, Mikael Mir, Ibtisam Rauf, Jain Nitesh, Salim Surani and Syed Anjum Khan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salim Surani, FCCP, MD, MHSc, Academic Editor, Professor, Department of Medicine & Pharmacology, Texas A&M University, 400 Bizzell St, College Station, TX 77843, United States. srsurani@hotmail.com |
| Key Words |
Sodium-glucose transporter 2 inhibitors; COVID-19; SARS-CoV-2; Diabetic ketoacidosis; Euglycemic diabetic ketoacidosis; Diabetes mellitus |
| Core Tip |
This systematic review provides a comprehensive analysis of the relationship between sodium-glucose cotransporter-2 (SGLT2) inhibitors, euglycemic diabetic ketoacidosis (eu-DKA), and coronavirus disease 2019 (COVID-19) in patients with diabetes. Despite maintaining optimal glycemic control, individuals using SGLT2 inhibitors are still susceptible to both drug-induced and unrelated diabetic ketoacidosis (DKA), with potential adverse consequences during COVID-19 infection. Clinicians should exercise caution when prescribing SGLT2 inhibitors to diabetic patients affected by COVID-19 and carefully consider alternative treatment strategies. A thorough understanding of the intricate interplay between SGLT2 inhibitors, euglycemic DKA, and COVID-19 is crucial for optimizing patient management and achieving favorable clinical outcomes. |
| Publish Date |
2023-08-25 08:26 |
| Citation |
Khedr A, Hennawi HA, Khan MK, Eissa A, Mir M, Rauf I, Nitesh J, Surani S, Khan SA. Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports. World J Clin Cases 2023; 11(24): 5700-5709 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i24/5700.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i24.5700 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
